Improved glycemic control and reduced bodyweight with exenatide: a double-blind, randomized, phase 3 study in Japanese patients with suboptimally controlled type 2 diabetes over 24 weeks
dulaglutide 3 mg and 4.5 mg for the treatment of people with type 2 diabetes not achieving glycaemic control on metformin in the UK
Schumer also talked about her experience on "Watch What Happens Live with Andy Cohen" in 2023, explaining (via Page Six), "I was one of those people that felt so sick and couldn't play with my son
6,7 GLP-1 was later identified in the 1980s as another primary incretin hormone responsible for the stimulation of insulin release to cover carbohydrate utilization following a meal
A safe stopping point means you have successfully tapered to the lowest dose or off the medication entirely, while maintaining weight stability, normal appetite signaling, and stable blood sugar control over at least 48 weeks post-discontinuation